Antibodies purified from sera of HIV-1-infected patients by affinity on the heptad repeat region 1/heptad repeat region 2 complex of gp41 neutralize HIV-1 primary isolates
Authors:
- 18 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (16) , 2075-2085
Abstract
Objective: The objective of this paper was to evaluate the presence and the neutralizing activity of antibodies directed against the complex formed between the two heptad repeat regions (HR1 and HR2) of HIV-1 gp41 in sera of HIV-1-infected patients. Research designs and methods: The HR1 region was represented by the peptide N36 and the maltose-binding protein (MBP)–HR1, the HR2 region by the peptide C34 and MBP44. Antibodies directed to the HR1/HR2 complex were purified from sera by affinity chromatography using MBP–HR1/C34 adsorbed onto a resin. Results: First, we demonstrated that human monoclonal antibodies, which are directed specifically to the HR1/HR2 complex recognized in enzyme-linked immunosorbent assay the MBP–HR1/C34 and MBP44/N36 mixtures but not the proteins or the peptides individually. We investigated the ability of 50 sera of HIV-1-infected patients to react with the MBP–HR1/C34 and MBP44/N36 complexes. We found that the majority of sera of HIV-1-infected patients recognized the HR1/HR2 complexes but not or to a lower extent the proteins or the peptides individually. Antibodies purified from sera by affinity chromatography using MBP–HR1/C34 adsorbed to a resin neutralized different primary HIV-1 isolates. Conclusion: The presence of antibodies directed to the HR1/HR2 complex in sera of HIV-infected patients highlights the immunogenic character of the complex, whereas the neutralizing activity of these antibodies suggests that immunogens representing HIV-1 HR1/HR2 complexes might be used in anti-HIV vaccine.Keywords
This publication has 35 references indexed in Scilit:
- A Monoclonal Fab Derived from a Human Nonimmune Phage Library Reveals a New Epitope on gp41 and Neutralizes Diverse Human Immunodeficiency Virus Type 1 StrainsJournal of Virology, 2007
- Characterization of the HIV N-terminal Fusion Peptide-containing Region in Context of Key gp41 Fusion ConformationsJournal of Biological Chemistry, 2006
- Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral EnvelopeJournal of Virology, 2003
- A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapyAIDS, 2003
- Monoclonal Antibodies That Bind to the Core of Fusion-Active Glycoprotein 41AIDS Research and Human Retroviruses, 2000
- Two Interaction Modes of the gp41-Derived Peptides with gp41 and Their Correlation with Antimembrane Fusion ActivityBiochemical and Biophysical Research Communications, 1999
- Monomer‐trimer equilibrium of the ectodomain of SIV gp41: Insight into the mechanism of peptide inhibition of HIV infectionProtein Science, 1999
- Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodiesInternational Immunology, 1997
- A trimeric structural domain of the HIV-1 transmembrane glycoproteinNature Structural & Molecular Biology, 1995
- HIV-1 inhibition by a peptideNature, 1993